Introduction
Obesity is growing in high income and low to middle-income countries alike, particularly in urban settings (Popkin et al., 2012) . As the rates of obesity continue to rise, insulin resistance is becoming one of society's major public health issues. Obesity is considered to be a result of an imbalance between calories consumed and calories expended (Hill et al., 2012) . Tissues such as muscle, fat and liver become less responsive to insulin and results in a state of insulin resistance;
this is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in the peripheral tissues, mainly muscle and adipose tissues (Wilcox, D r a f t 5 of this shrimp is rich in lipids. A recent study showed that Northern shrimp oil contains not only a high content of n-3 PUFA but also a high concentration of antioxidants (Subramanian et al., 2015) , the latter are also beneficial to metabolic health and glucose homeostasis (Vincent et al., 2009 ). However, the heads and tails of shrimp are disposed as a waste material at shrimp processing plants, impacting the environment and increasing production cost. The reason that shrimp heads and tails are discarded as waste by the processing industry is the lack of understanding regarding their nutritional value and potential for value-added products. As a result, the industry has not invested in technology and equipment required to efficiently extract valuable ingredients such as n-3 PUFAs and antioxidants from the waste stream. With our recent development of an extraction technology (US 20160145533 A1), efficient extraction and preservation of oil from shrimp processing wastes has become feasible. The present study reports that PUFA-rich oil extracted from the shrimp processing waste with this technology has beneficial effects on insulin sensitivity, glycemic control, and other metabolic phenotypes associated with diabetes in a rat model of insulin resistance.
Methods and Materials
D r a f t 6 solids from liquids. The liquid phase containing mainly water and oil was pumped into a 3-phase vertical centrifuge to separate oil from water and solid residues. The oil fraction was used for animal studies.
After washing with 5 mL hexane, a Supelclean™ LC-Si SPE cartridge (Sigma-Aldrich Corp., St Louis, MO, USA) was loaded with 10 mL of shrimp oil dissolved in 5 mL hexane. The cartridge was eluted with 2 x 5 mL hexane containing 6% diethyl ether to obtain a triacylglycerol-rich fraction and then 2 x 5 mL acetone containing 200 mg/L BHT to obtain the pigment fraction. The two acetone fractions were pooled, evaporated under nitrogen and stored at -20 °C until analysis.
Analysis of astaxanthin in shrimp oil
The shrimp oil was subjected to a solid phase extraction to separate sterols, carotenoids and other components using silica Strat-si-1 cartridge (Phenomenex Inc., Torrance, CA). The astaxanthin was released from the mono and di-esters following the reported method (Del Campo et al., 2004) and analyzed on an Varian Prostar 240 HPLC (Agilent Technologies, Mississauga, ON) according to the method described elsewhere (Yuan and Chen, 1997) .
Analysis of vitamins A and E in shrimp oil
The content of vitamin A in shrimp oil was measured according to an AOAC (Association of Official Analytical Chemists) method (AOAC 2001 (AOAC .13-2001 while the content of vitamin E was determined using an AACC (American Association of Clinical Chemistry) method (AACC 86-06) using the HPLC.
Analysis of fatty acids in shrimp oil
An aliquot of shrimp oil was transferred to a screw-capped glass tube that contains 1 mg of nonadecanoic acid (C19:0) as an internal standard and evaporated to dryness under nitrogen.
Fatty acids were trans-esterified by re-dissolving the dried lipid samples in 3 mL of methanol/toluene mix (3:2, v/v) with additional 2 ml of 5% acetyl chloride in methanol. The tubes were flushed with nitrogen, closed tightly and heated at 100ºC for 1 hr, with gentle shaking every 15 min. After cooling to room temperature, 4 mL of distilled water and 1 mL of hexane were added. The tubes were shaken vigorously and centrifuged at 2,000 rpm for 2 min. The hexane/toluene phase containing methylated fatty acids was transferred to a GC vial. An Agilent DB-WAX capillary column (20 m x 0.18 mm ID x 0.18 µm) on an Agilent 7890B GC (Agilent Technologies, Mississauga, ON), equipped with an autosampler, a purge ultimate union backflush and flame ionization detector, was used to separate and quantify the fatty acid methyl esters. One µL of sample was injected onto the column using a split mode (1:50) and hydrogen was used as the carrier gas. The initial column/oven temperature was set at 140ºC for 0.2 min, increased to 170ºC at 40ºC/min and held for 3 min, then to 185ºC at 4.9ºC/min, further to 200ºC at 2.5ºC/min and held 3 min, and finally ramped to 220ºC at 2.5ºC/min. At the end of each run, the purge ultimate union backflush was used to flush out the sterols and other less volatile compounds through the split line of the injection port. Individual fatty acids were identified against the retention time of corresponding standards running in parallel with the samples, and quantitated in reference to the internal standard. Male CD rats (200-225 g) were obtained from Charles River (Saint Constant, QC, Canada) and housed individually in rat cages with a 12-hr light:dark cycle and free access to rodent chow and water. After 7 days of adaption, body weight was obtained and blood glucose was measured.
Rats and diets
Rats were then randomly assigned based on body weight and blood glucose concentration into two groups of 12 rats and 48 rats, respectively. The group of 12 rats was fed a low-fat control (LFC) diet and the remaining 48 rats were fed a high-fat control (HFC) diet. A week later, rats on the HFC diet were segregated into four groups. One group was used as the control (continued on the regular HFC diet) whereas the other three groups were fed the HFC diet with 10% (SO10), 15% (SO15), or 20% (SO20) of lard being replaced with shrimp oil. The composition of diets is provided in Supplementary table S1. Rats on the HFC, SO10, SO15 and SO20 diets also received 20% fructose-drinking water, which was started at the same time as the HFC diet and prepared every other day. The inclusion of 20% fructose in drinking water in addition to the high-fat diet was used to accelerate the development of insulin resistance (Stranahan et al., 2008) . Rats were weighed weekly and food intake was monitored daily for 10 weeks. At the end of the study, the rats were fasted overnight and then anesthetized by inhalation of isoflurane (Pharmaceutical Partners of Canada Inc. Richmond Hill, ON, Canada) and blood was collected immediately via cardiac puncture into serum and plasma tubes (BD Biosciences, ON, Canada).
The rats were euthanized by cervical dislocation and the liver was immediately dissected,
weighed, and flash-frozen in liquid nitrogen. Serum, plasma and liver samples were stored in a -80°C freezer.
Glucose and insulin tolerance tests
Oral glucose tolerance test (OGTT) was carried out during weeks 4 and 9 of the treatment and insulin tolerance test (ITT) was conducted in all rats during week 10 of treatment after 4-hr fasting as reported previously (Wang et al., 2015) . The area under the curve (AUC) of blood glucose levels was calculated for the OGTT and ITT, respectively.
Analytical of blood glucose and lipids
The fasting serum glucose concentration was measured in triplicate as reported previously (Wang et al., 2015) . The fasting serum total cholesterol (T-C), HDL cholesterol (HDL-C) and triacylglycerol (TAG) were measured in triplicate following the published methods (Wang et al., 2014) . The serum free fatty acid was determined in duplicate using commercial kits following the kit instructions (Abcam Inc., Toronto, ON, Canada).
Measurement of serum insulin, leptin, adiponectin, and HbA1c
Glycated hemoglobin (HbA1c) in the fasting serum was measured in duplicate using a commercial assay kit (Crystal Chem, IL, USA) following the kit instructions. The concentration of serum insulin, leptin, and adiponectin was also measured using the ELISA kits, with the rat insulin kits being obtained from Mercodia (Uppsala, Sweden), leptin kits from R&D Systems 1.56-100 ng/ml, 0.15-5.5 µg/ml, and 62.5-4,000 pg/ml for adiponectin, insulin and leptin ELISA kits, respectively. All samples were within the detection range except those for adiponectin for which a dilution factor of 1:400 was applied.
Measurement of inflammatory biomarkers
The serum concentrations of C-reactive protein (CRP), tumor necrosis factor-α (TNF-α),
interleukin-6 (IL-6), interleukin-1β (IL-1β), and monocyte chemoattractant protein-1 (MCP-1)
were measured in duplicate using commercial ELISA kits following the kits instructions. The rat CRP ELISA kit was from Abcam Inc. (Toronto, ON, Canada), the TNF-α kit from Biolegend (San Diego, CA, USA), the IL-1β and MCP-1 ELISA kits from Affymetrix-eBioscience (San Diego, CA, USA), and the IL-6 ELISA kit from Cusabio (Wuhan, Hubei, China). The coefficient of variation between replicates was 7.4%, 6.7%, < 10%, < 8%, and < 4.9% for TNF-α, MCP-1, IL-1β, IL-6, and CRP assays, respectively. The detection range was 7.5-800 pg/ml, 0.31-20 pg/ml, and 0.78-50 ng/ml for the TNF-α, IL-6 and CRP, respectively. The sensitivity was > 4.7 pg/ml and > 4 pg/ml for the MCP-1 and IL-1β assays, respectively. The samples were diluted at 1:60,000 for CRP analysis.
Measurement of oxidative stress biomarkers
The activity of catalase, superoxide dismutase (SOD), glutathione peroxidase (PGx), glutathione reductase (GR), reduced glutathione (GSH), oxidized glutathione (GSSG), and thiobarbituric acid reactive substances (TBARS) in the liver and the concentration of total antioxidants in the serum (1:20 dilution) were measured in duplicate using the commercial assay kits (Cayman chemicals, MI, USA) following the kits instructions. It should be noted that TBARS assay is D r a f t 11 non-specific, measuring several products of oxidative stress rather than directly measure reactive oxygen species, which have extremely short half-lives (Pryor, 1991).
Calculation of homeostatic model assessment of insulin resistance
The homeostatic model assessment of insulin resistance (HOMA-IR) was calculated as (glucose in mmol/L × insulin in mU/L)/22.5.
Statistical Analysis
All analyses were performed using SAS software version 9.2 (SAS Institute, North Carolina, USA). The difference between the HFC and LFC was analyzed using the Student's t-test. The treatment effect was analysed using one-way ANOVA. Repeated measures t-test and repeated measures one-way ANOVA were employed for the parameters that were measured multiple times. When a significant treatment effect was obtained, differences among the HFC, SO10, SO15 and SO20 were determined by using the least squares means test adjusted to Tukey.
Significance level was set at p < 0.05. The results are presented as means ± S.E.M (n = 11-12).
Results

Composition of shrimp oil
The shrimp oil used in the present study contains ≥ 95% of triacylglycerols and 1.7% sterols (Subramanian et al., 2015) . Although not measured in the present study, the phospholipids content was estimated to be less than 3% considering that the oil also contains a small amount of free fatty acids and other fat-soluble components. Fatty acid composition and content of shrimp oil are provided in Supplementary table S2. It was found that this oil contained a low content of D r a f t saturated fatty acids (18.2%) while having high levels of MUFA (54.6%) and PUFA (27.2%).
Moreover, there were many different MUFA with different positions of the first double-bond.
The predominant MUFA were C18:1n-9 (13.0%), C16:1n-7 (12.0%), C22:1n-11+13 (9.7%), C20:1n-9 (7.5%), C18:1n-7 (4.1%), C22:1n-9 (2.6%), and C20:1n-7 (2.3%). A high level of n-3 PUFA, especially EPA (9.9%) and DHA (10.3%), was another beneficial characteristic of this oil. Thus, the fatty acid composition of the experimental diets differed substantially. The saturated fatty acids decreased whereas the monounsaturated and polyunsaturated fatty acids increased with the replacement of 10-20% dietary lard with shrimp oil. There was a marked increase of n-3, especially EPA and DHA, while n-6 fatty acids were decreased by replacing lard with shrimp oil (Supplementary table S3 ). In addition to its fatty acid profile, shrimp oil used in the present study was also analyzed for the content of antioxidants (Supplementary table S4) .
Ketocarotenoid astaxanthin (≥ 400 µg/g), vitamin E (≥ 50 IU/100g) and vitamin A (≥ 1000 RE/100g) were the main antioxidants. Furthermore, astaxanthin in this shrimp oil existed as 75% diesters and 23% monoesters and of the total astaxanthin, 57% was trans-astaxanthin and 43%
was cis-astaxanthin (Subramanian et al., 2015) . In addition, the oil contained 1.7% sterols and of which 0.8% was cholesterol (Subramanian et al., 2015) . Analysis for contaminants in the shrimp oil revealed that dioxins, furans and polychlorinated biphenyls were below the levels of detection or the acceptable limits for consumption set by regulatory agencies such as the Canadian Food Inspection Agency (data not shown).
Body weight and food intake
As shown in Table 1 , the HFC group had higher (p < 0.05) body weights than the LFC group.
However, no differences were found among the HFC, SO10, SO15 and SO20 groups. The food D r a f t 13 intake was lower (p < 0.05) in the HFC group than in the LFC group ( Table 2) . The shrimp oil supplementation did not alter food consumption from week 1 to week 9 of the treatment. On week 10, food intake increased in the HFC group whereas it decreased in the SO10, SO15 and SO20 groups (p < 0.01).
Shrimp oil improves oral glucose tolerance
Semi-fasting (4-hr) blood glucose was elevated in the HFC group as compared to the LFC group from week 7 to the end of the study ( Table 3 ). The three doses of shrimp oil did not show significant effects compared to the HFC group. The fasting (12-hr) serum glucose levels did not differ among the HFC, LFC and treatment groups ( Table 4) .
The oral glucose loading induced significant increases of blood glucose level in rats of the HFC group at every time point post oral glucose loading compared to the LFC control in weeks 4
( Figure 1A ) and 9 ( Figure 1B ) of the treatment, respectively, indicating that glucose intolerance was developed in the HFC group as a result of free access to the high-fat diet and 20% fructosedrinking water. This effect was reversed completely or partially by replacing a small portion of dietary lard with shrimp oil. In the first oral glucose tolerance test conducted during week 4 of the treatment, rats of the SO20 group showed lower (p < 0.05) blood glucose levels at 90 and 120 min after the oral glucose loading ( Figure 1A) . The same test was repeated in week 9 of the treatment. The blood glucose levels was lowered (p < 0.05) in both the SO20 and SO15 groups at 60, 90, and 120 min ( Figure 1B ) and the SO20 group also showed lower (p < 0.05) glucose levels at 30 min compared to the HFC group. Despite a lack of an effect on body weight, replacing 20% or 15% of dietary lard by shrimp oil resulted in a significant improvement of oral D r a f t 14 glucose tolerance. Consistently, the AUC of OGTT in either week 4 or week 9 of the treatment showed significant benefits of shrimp oil ( Table 5 ). The AUC was higher (p < 0.01) in the HFC group than in the LFC group in both OGTTs. It was reduced (p < 0.01) by 7% in the SO20 group in week 4 of treatment. A better effect was seen in week 9 of treatment, with a 12% reduction (p < 0.001) being observed in the SO20 group relative to the HFC group. In this test, the SO15 also showed a significant effect and 11% lower (p < 0.01) than the HFC group.
Shrimp oil improves insulin sensitivity
Further to the oral glucose tolerance test, an insulin tolerance test was performed to determine the effect of shrimp oil on insulin sensitivity. Rats of the HFC group showed higher (p < 0.05) levels of blood glucose at 0, 30, 60, 90, and 120 min, respectively, than those of the LFC group after the intraperitoneal insulin injection (Figure 2) , suggesting that rats fed the high-fat diet developed insulin resistance. Interestingly, when dietary lard was partially replaced by shrimp oil the body response to the injected insulin was significantly improved. As a result, rats in the SO20 group showed markedly lower (p < 0.05) glucose levels at all time points except 30 min post insulin injection. The blood glucose levels were also lowered (p < 0.05) in the SO15 group at 60, 90, and 120 min and in the SO10 group at 90 and 120 min compared to the HFC group.
Consistently, the HFC group had a higher (p < 0.001) AUC than the LFC group ( (Table 4) . Strikingly, the elevation of HbA1c in the HFC group was reversed by replacing dietary lard with shrimp oil at the dose of 10, 15, or 20%. Similarly, the serum concentrations of insulin and leptin were elevated (p < 0.01) in the HFC group compared to that in the LFC group, whereas they were dose-dependently lowered in the SO10, SO15, and SO20 groups, respectively. Serum insulin was lower (p < 0.01) in the SO20 group as was serum leptin (p < 0.05) relative to the HFC group. In contrast, the serum adiponectin was decreased by 40% (p < 0.001) in the HFC group compared to the LFC group, which was reversed by the replacement of dietary lard with shrimp oil. Compared to the HFC group there were 43%, 52%, and 60% increases (p < 0.01) of serum adiponectin concentrations in the SO10, SO15 and SO20 groups, respectively. The HOMA-IR is calculated based on the fasting blood glucose and insulin concentrations and widely used to assess the severity of insulin resistance. The present study showed a higher (p < 0.001) HOMA-IR index in the HFC group than the LFC group. This effect was improved by shrimp oil in a dose-dependent manner, resulting in a significantly lower (p < 0.05) value in the SO20 group than the HFC group.
Shrimp oil improved serum lipid profile
The replacement of dietary lard with shrimp oil dose-dependently lowered the serum total cholesterol and a significant difference was observed between the SO20 and HFC groups (p < 0.05) although no difference was observed between the HFC and LFC groups ( Table 4) . The
The present study demonstrated that rats fed the high-fat diet and fructose-drinking water gained more weight and became obese as compared with those given the low-fat diet, developed glucose intolerance and insulin and leptin resistance, and increased production of pro-inflammatory cytokine TNF-α. These observations are in agreement with previous reports (Geng et al., 2016; Huang et al., 2004) . Interestingly, these effects were reversed or significantly improved by replacing up to 20% of lard in the diet with shrimp oil. As the total fat content in each diet was identical, the improvements in glucose intolerance and insulin and leptin resistance are considered to be a result of the components of shrimp oil that are different from lard.
The improvement of oral glucose intolerance by shrimp oil was demonstrated by the results of two separate oral glucose tolerance tests, which are commonly used in both animal and human studies to evaluate glucose tolerance (Wang et al., 2015) . The insulin resistance test further demonstrated that the impaired oral glucose tolerance was, at least in part, a result of a reduced response to insulin. This notion was supported by HOMA-IR index, which has been increasingly used to assess insulin resistance (Matthews et al., 1985; Singh and Saxena, 2010) . This index was substantially elevated in rats fed the high-fat diet but improved with shrimp oil in a dosedependent manner, becoming normal when 20% lard was replaced with shrimp oil. Blood concentrations of insulin and leptin are important biomarkers of obesity and diabetes and vice versa (Considine et al., 1996; Koch et al., 2014; Wilcox, 2005) . Rats on the HFC diet and fructose drinking water had blood insulin and leptin levels twice as much as those on the LFC improves insulin sensitivity. Dietary supplementation of n-3 PUFA, in particular EPA and DHA, increases the serum concentration of adiponectin in humans and animals (Gray et al., 2013; Sabour et al., 2015) . Recent reports demonstrated that replacing saturated fatty acids with n-3
PUFA lowers blood glucose and HbA1c levels, HOMA-IR index, and insulin secretion in humans (Imamura et al., 2016; Iwasaki et al., 2012) . Second, astaxanthin, vitamins E and vitamin A in shrimp oil increase antioxidant capacity and reduce oxidative stress (Sadighara et al., 2014) .
High-fat, high-fructose consumption decreases the body total antioxidant capacity, along with the inactivation of catalase and glutathione peroxidase, leading to an increase of hydrogen peroxide levels that in turn inactivate superoxide dismutase and increase superoxide anions (Savini et al., 2013) . Antioxidants quench free radicals, which otherwise cause lipid peroxidation and oxidative stress and consequently the peripheral tissue insulin resistance and damage of pancreatic β-cells (Meydani et al., 1991) . Astaxanthin is a strong antioxidant (Ambati et al.,
2014
) and a product of astaxanthin purified from shrimp is reported to lower malondialdehyde levels, enhance the activities of superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase, and increase the ratio of GSH to GSSG in alloxan-induced diabetic rats (Sila et al., 2015) . Similar effects were observed in the present study. Vitamins A and E are decreased in diabetes (Valdes-Ramos et al., 2015) , and accordingly the supplementation of shrimp oil may improve the status of these two vitamins.
D r a f t 20
The anti-inflammatory effects of shrimp oil might have provided an additional protection against the development of insulin resistance as chronic inflammation is well-known to be related to obesity and diabetes (Wellen and Hotamisligil, 2005) . Excess fat storage and acute hyperglycemia release pro-inflammatory cytokines into the circulating system, leading to increases of chronic inflammation in the peripheral tissues and development of insulin resistance (Johnson et al., 2012) . The consumption of the high-fat diet and high-fructose drinking water induced a dramatic increase of the serum concentration of TNF-α that was reversed dosedependently by dietary shrimp oil. This may be attributed to the inhibitory effects of shrimp oil n-3 PUFAs (Siriwardhana et al., 2012; Trebble et al., 2003) and antioxidants (Cordero-Herrera et al., 2015; Fassett and Coombes, 2011; Rizvi et al., 2014) on chronic inflammation. The increased serum total cholesterol level in the HFC rats was consistent with the earlier studies (Akiyama et al., 1996; Nair et al., 2014) , indicating that lipid metabolism was altered by high fat and/or fructose intake. The reduction of serum total cholesterol was probably a result of bile acids sequestration and subsequent excretion from the body (Smit et al., 1991) . Furthermore, shrimp oil contained a lower concentration of saturated fatty acids, especially palmitic acid, which promotes synthesis of cholesterol (Fernandez and West, 2005) .
The anti-diabetic effect of shrimp oil observed in male rats is anticipated in females (Ohta et al., 2014) . However, sex differences were observed in the progression and extent of insulin resistance and diabetes (Mauvais-Jarvis, 2015). Strain differences also exist, for example, the metabolic effects caused by a high-fat diet seemed to be more pronounced in Wistar than in SD 
Conclusion
Feeding of a high-fat diet and fructose in drinking water to rats induced rapidly obesity and insulin resistance. Replacement up to 20% of dietary lard with shrimp oil produced substantial improvements in oral glucose tolerance and insulin and leptin resistance, accompanied by the reductions of chronic inflammation and oxidative stress. Shrimp oil supplementation reversed reductions of the adiponectin and increases of free fatty acids in the blood, and decreased blood total cholesterol caused by high-fat diet and fructose-drinking water. These effects of shrimp oil supplementation occurred in the absence of a change in body weight. Shrimp oil is a promising functional food ingredient for the prevention and treatment of insulin resistance and type 2 diabetes.
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The difference between the HFC and LFC groups was analyzed using repeated measures t-test. The treatment effect was analysed using repeated measures one-way ANOVA and differences among the HFC, SO10, SO15, and SO20 were determined using the least squares means test adjusted to Tukey. The significance least level was set to 0.05. The results are presented as means ± S.E.M. (n = 11-12 
D r a f t 37
The difference between the HFC and LFC was analyzed using paired student t-test. The treatment effect was analysed using one-way ANOVA and differences among the HFC, SO10, SO15, and SO20 were determined using the least squares means test adjusted to For the AUC of OGTT, the repeated measures t-test and repeated measures one-way ANOVA were used. For the AUC of ITT, difference between the HFC and LFC groups was analyzed using t-test and the treatment effect was analysed using one-way ANOVA. Differences among the HFC, SO10, SO15, and SO20 were determined using the least squares means test adjusted to Tukey. The significance least level was set to 0.05. The results are presented as means ± S.E.M.
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